Upcoming Pegozafermin NASH Readout!
Summary: The upcoming readout from ETNB includes Phase 2b data from the pegozafermin trial in NASH. This is a Suspected Mover for Q1...
${alertText}
Want unlimited access? Try Pro free for 7 days.
Upcoming Pegozafermin NASH Readout!
Biopharma Daily Pulse - 08/17/22
Free Biopharma Daily Pulse - 08/17/22
Biopharma Mid Morning Pulse - 07/20/22
Big/Suspected Movers FAQ/User Guide
Quarterly Big Mover Biotech Stocks To Watch
Q2 2023 Product Revenue Analyses
BPIQ Q2 2023 Biotech Hedge Fund (13F) Analysis
SYFOVRE (APLS) vs. IZERVAY (Astellas)
BIIB & SAGE: Zuranolone
Apellis Pharmaceuticals (APLS)
Our platform helps you uncover your next biotech investment opportunity